Delivery Order SPE2DB22D1017-SPE2DB23FG2XN
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,667.54 for 10,000 units of chorionic gonadotropin (a hormone treatment product) on June 4, 2025, with completion scheduled for June 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,113.19 to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin (a hormone treatment) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price, non-set-aside contract represents a competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $5,985.23 delivery order to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin, a hormone-based pharmaceutical product commonly used in fertility treatments and medical therapies. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement under a competitively awarded arrangement with no set-aside designation. Performance of this delivery order is based in...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.23 to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin (a hormone treatment product) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the prime contractor, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is...
- The Defense Logistics Agency Troop Support Medical awarded a $1,699 firm fixed price delivery order against an unidentified contracting vehicle to Amerisourcebergen Drug Corp Corporate Office Division. The order is to provide 10,000 units of Chorionic Gonadotropin for use by DLA Troop Support Medical in supporting Department of Defense programs. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work to be completed by June 26, 2023. No subcontractors...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10,000 units of Chorionic Gonad, a pharmaceutical product, with a potential value of $5,956.73. The contract has a performance period through March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract the company holds...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order contract is valued at $3,783.72 and runs through July 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans...
- This federal contract award is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 25, 2024, with a ceiling value of $24,197.44 and a completion date of March 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,184.77 firm fixed-price delivery order is for the procurement of 10,000 units of Chorionic Gonad, a medical product, with a performance completion date of November 23, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 10,000 units of Chorionic Gonad, a pharmaceutical product. The firm fixed price contract has a potential value of $6,374.49 and a completion date of December 29, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to...